IMD WATCH
In association with the NSPKU
LOW PROTEIN DIETS IN METABOLIC DISORDERS: AN OVERVIEW Suzanne Ford NSPKU Dietitian for Adults Suzanne Ford works as a Metabolic Dietitian for Adults at North Bristol NHS Trust. She has been a Dietitian for 21 years, with six of them working in Metabolic Disease.
For full article references please email info@ networkhealth group.co.uk
In this article, I will cover the principles of low protein diets, the nutritional and practical challenges posed and how metabolic dietitians and patients are collaborating to seek and share knowledge of good practice and develop the evidence base. In Metabolic Dietetics (and in healthcare in general) we can all expect to see more patients in the future with disorders needing low protein diets. In 2015, the newborn screening panel was expanded to include four additional metabolic disorders; so, the improved diagnosis and management will see higher numbers of patients surviving into adulthood. Low protein diets are a key feature of Metabolic Dietetics and there are two broad types: one is the safe protein diet which may be used in urea cycle disorders, organic academics etc, and the second is the exchange based diet for phenylketonuria, tyrosinaemia, homocysteinuria and isovaleric acidaemia. This requires commitment from the patients or families and knowledge, skill and clinical judgement from dietitians. In both these groups of diets, the evidence base and food analysis knowledge is incomplete and evolving. The aims of a low protein diet are to: • minimise the production of toxic metabolites; • supply all amino acids for any growth and development; • supply amino acids for basic tissue turnover; • minimise the release of any endogenous toxic metabolites caused by catabolism. SAFE PROTEIN DIET
WHO/FAO/UN 2007 Safe protein levels are given in age and gender
Table 1: WHO/FAO/UN 2007 Safe Protein levels Age
Intake g/kg bw /day
16y
0.84
17y
0.83
18y
0.82
>18y
0.83
specific grams per kilo of body weight. (Pregnancy and lactation have been omitted, as I will not cover those in this piece.) The amount of natural protein tolerated by patients with different disorders will vary dependent on the disorder itself and the individual's phenotype, i.e. the expression of the genetic mutation they have. In many cases, protein allowances are titrated up from infancy through childhood to adulthood, using a combination of prediction equations and biochemical monitoring in conjunction with nutritional intake analysis. Practices throughout UK metabolic centres and also European centres have been surveyed and published in the last five years and consensus clinical guidelines are under development, or have been published for metabolic disorders such as homocystinuria. The practices surveyed for low protein diet prescriptions focused on both the gram per kilo protein prescribed or used and also the use of essential amino acids (EAA). EAA are used to achieve normal growth and metabolic stability (if a particular amino acid
www.NHDmag.com August/September 2017 - Issue 127
33